|
|||||
|
|
Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study |
|
| Authors: | Katrina S. Pedersen George P. Kim Nathan R. Foster Andrea Wang-Gillam Charles Erlichman Robert R. McWilliams |
| Affiliation: | 1. Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA 4. Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA 2. Department of Biomedical Statistics and Informations, Mayo Clinic, Rochester, MN, USA 3. Division of Oncology, Washington University, Saint Louis, MO, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |